Trial Profile
Pivotal bioequivalence study of an undisclosed opioid abuse-deterrent product (Elite Pharmaceuticals)
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 16 Jan 2014
Price :
$35
*
At a glance
- Drugs Opioid analgesics (Primary)
- Indications Opioid-related disorders; Pain
- Focus Pharmacokinetics; Registrational
- Sponsors Elite Pharmaceuticals
- 16 Jan 2014 New trial record